Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume 29, Issue 10, Pages 1807736
Publisher
Wiley
Online
2019-01-24
DOI
10.1002/adfm.201807736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-Assembled Peptide–Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery
- (2018) Jin Yan et al. ACS Nano
- Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
- (2018) Fan Niu et al. BIOMATERIALS
- Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
- (2018) Christopher D. Spicer et al. CHEMICAL SOCIETY REVIEWS
- Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells
- (2018) Long Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch
- (2018) Wangxiao He et al. CHEMISTRY OF MATERIALS
- Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy
- (2018) Wangxiao He et al. ACS Nano
- Opportunities and challenges in phenotypic drug discovery: an industry perspective
- (2017) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer Activity
- (2017) Qing Zhou et al. Theranostics
- Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration
- (2016) Hong-Jun Li et al. ACS Nano
- The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment
- (2015) Jinqiang Wang et al. ACS Nano
- Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy
- (2015) Hao-Nan Chang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Simultaneously targeted imaging cytoplasm and nucleus in living cell by biomolecules capped ultra-small GdOF nanocrystals
- (2015) Jin Yan et al. BIOMATERIALS
- Modulating protein–protein interactions: the potential of peptides
- (2015) Laura Nevola et al. CHEMICAL COMMUNICATIONS
- PD-1/PD-L1 inhibitors
- (2015) Joel Sunshine et al. CURRENT OPINION IN PHARMACOLOGY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Rational Design of Selective Small-Molecule Inhibitors for β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interactions
- (2015) Logan R. Hoggard et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network
- (2013) Xuefei Li et al. CANCER LETTERS
- Wnt signaling in stem and cancer stem cells
- (2013) Jane D Holland et al. CURRENT OPINION IN CELL BIOLOGY
- Photocatalytic and antibacterial properties of Au-TiO2 nanocomposite on monolayer graphene: From experiment to theory
- (2013) Wangxiao He et al. JOURNAL OF APPLIED PHYSICS
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Reversible Plasmonic Circular Dichroism of Au Nanorod and DNA Assemblies
- (2012) Zhengtao Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Protein–protein interaction inhibitors get into the groove
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Disruption of the BCL9/ -Catenin Complex Inhibits Oncogenic Wnt Signaling
- (2012) K. Takada et al. Science Translational Medicine
- An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid
- (2012) Marc de la Roche et al. Nature Communications
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model
- (2011) Huan Meng et al. ACS Nano
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Improving the Yield of Mono-DNA-Functionalized Gold Nanoparticles through Dual Steric Hindrance
- (2011) Zhengtao Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
- (2010) Sarbari Acharya et al. ADVANCED DRUG DELIVERY REVIEWS
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Nonviral Vectors for Gene Delivery
- (2008) Meredith A. Mintzer et al. CHEMICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More